Mesenchymal cells contribute to the 'stroma' of most normal and malignant tissues, with specific mesenchymal cells participating in the regulatory niches of stem cells. By examining how mesenchymal osteolineage cells modulate haematopoiesis, here we show that deletion of Dicer1 specifically in mouse osteoprogenitors, but not in mature osteoblasts, disrupts the integrity of haematopoiesis. Myelodysplasia resulted and acute myelogenous leukaemia emerged that had acquired several genetic abnormalities while having intact Dicer1. Examining gene expression altered in osteoprogenitors as a result of Dicer1 deletion showed reduced expression of Sbds, the gene mutated in Schwachman-Bodian-Diamond syndrome-a human bone marrow failure and leukaemia pre-disposition condition. Deletion of Sbds in mouse osteoprogenitors induced bone marrow dysfunction with myelodysplasia. Therefore, perturbation of specific mesenchymal subsets of stromal cells can disorder differentiation, proliferation and apoptosis of heterologous cells, and disrupt tissue homeostasis. Furthermore, primary stromal dysfunction can result in secondary neoplastic disease, supporting the concept of niche-induced oncogenesis.
Mesenchymal cells are a part of virtually every tissue in metazoans, and are thought to participate in organ formation, cellular composition, patterning and size. In adult tissues, these cells are considered stroma without clear function. Identification of somatic stem cell populations has made the study of heterologous cells comprising their niche possible. Mesenchymal cells of osteolineage have been shown to regulate haematopoietic stem cells (HSC) 1, 2 , with osterix (also known as Sp7)-expressing skeletal progenitors initiating ectopic HSC niche formation 3 . We previously examined mesenchymal-HSC interactions using mice engineered to express individual genes in osteoblastic cells 1, 4 , and now sought to define more precisely the stage of osteolineage differentiation critical for haematopoiesis using promoters more restricted in their expression to alter candidate genes. We chose to alter a gene that could modulate a landscape of other gene products.
Dicer1 is an RNase III endonuclease essential for microRNA (miRNA) biogenesis 5 and RNA processing 6 . miRNAs regulate haematopoietic cell fate 7 , and their global downregulation by Dicer1 deletion promotes tumorigenesis in a cancer-cell-autonomous manner 8 . We used Dicer1 deletion as a means of altering several gene products in subsets of mesenchymal osteolineage cells. We intercrossed mice expressing green fluorescent protein (GFP)-Cre recombinase under the transcriptional control of the osterix 9 promoter expressed in osteoprogenitor cells to mice with floxed Dicer1 alleles 10 , generating Osx-GFP-Cre 1 Dicer fl/1 (OCD fl/1 control) and Osx-GFP-Cre 1 Dicer fl/fl (OCD fl/fl mutant) mice. The Cre transgene in this model is expressed coordinately with endogenous osterix 11 (Fig. 1a ). Mutant mice were born at Mendelian frequency, but showed growth retardation and impaired survival (,30% mutant mortality by 8 weeks). Therefore, we examined mice at 4-6 weeks of age.
Impaired osteoblastic differentiation
Dicer1 gene deletion in bone was shown by genomic PCR (Fig. 1b ) and its efficiency confirmed by quantitative PCR of Dicer1 messenger RNA in primary GFP 1 (CD45 2 lineage 2 CD31 2 ) cells ( Fig. 1c, d and Supplementary Fig. 1a, b ). Dicer1 was not deleted in haematopoietic stem and progenitor cells ( Fig. 1e ) nor in other haematopoietic subpopulations (not shown). Bone marrow stromal osteogenic colony number was decreased relative to total colony forming number (colony-forming unit alkaline phosphatase (CFU-ALK)/CFUfibroblast (CFU-F)), indicative of reduced osteogenic differentiation ( Fig. 1f, g) . OCD fl/fl bone marrow stromal cultures also demonstrated decreased alkaline phosphatase and calcified matrix deposition after osteogenic differentiation ( Supplementary Fig. 1d ). In vivo, osteoblasts from OCD fl/fl mice expressed less of the terminal differentiation marker osteocalcin (also known as Bglap) ( Fig. 1h and Supplementary Fig. 1e ). Altered texture of the mineralized bone matrix was observed ( Supplementary Fig. 1f ), but not reduction in trabecular or cortical bone volume ( Supplementary Fig. 1g , h). Osteoblast number was modestly, although significantly, decreased, whereas osteoclast number and function were not affected ( Supplementary  Fig. 1i -k and data not shown). Taken together, the data show that Dicer1 deletion in osteoprogenitors impairs osteoblastic differentiation both in vitro and in vivo.
Myelodysplasia in OCD fl/fl mice
Leukopenia with reduced numbers of cells in all leukocyte subsets was found in OCD fl/fl mice ( Fig. 2a and Supplementary Fig. 2a ). Erythrocyte and platelet counts varied widely in OCD fl/fl mice, with some animals showing profound anaemia and thrombocytopenia (Fig. 2a ). The variability was at least partly explained by extramedullary haematopoiesis in the spleen ( Supplementary Fig. 3 ), mitigating cytopenia in those animals. The bone marrow of OCD fl/fl mice was normoto hypercellular ( Supplementary Fig. 2b, c) . No significant differences were found in the frequency of immunophenotypically defined haematopoietic stem (lineage 2 c-kit 1 Sca1 1 (LKS) CD150 1 CD48 2 ) and progenitor (LKS) cells ( Supplementary Figs 2d, e and 4 ). Limitingdilution transplant analysis showed an increase in HSCs in mutants that did not reach statistical significance (1:29,000 versus 1:52,000, P 5 0.14). HSC and progenitor function were not impaired in OCD fl/fl mice, as demonstrated by competitive reconstitution capacity after transplantation or colony-forming unit (CFU in culture (CFU-C)) analysis ( Supplementary Fig. 2f , g). Decreased blood cell counts despite normal bone marrow cellularity and normal to increased stem cell function is characteristic of ineffective haematopoiesis.
Morphological assessment showed marked dysplasia, with nuclear hypersegmentation in neutrophils and giant platelets in the blood, and micro-megakaryocytes with hypolobulated, hyperchromatic nuclei in the bone marrow of OCD fl/fl mice (Fig. 2b, c and Supplementary  Fig. 5a -c). There was neither increased fibrosis on reticulin staining nor ring sideroblasts on iron stains of the bone marrow (not shown). Peripheral cytopenia with dysgranulopoiesis and dysplastic megakaryocytes is consistent with a diagnosis of myelodysplastic syndrome (MDS) in mice according to the Bethesda criteria 12 . The aetiology of human MDS is complex and poorly understood. It has been very difficult to engraft and propagate the haematopoietic characteristics of human MDS in mouse models by transplanting haematopoietic cells from MDS patients into immunodeficient mice, sparking a longstanding debate about a potential causative or facilitating role of the microenvironment in the pathogenesis of this disease.
Examining other principle characteristics of the human disease, we observed increased apoptosis and proliferation of primitive haematopoietic progenitors (Fig. 2d , e and Supplementary Figs 6-8a) 13 . Increased apoptosis was limited to primitive progenitor cells, as no differences were observed in differentiated (lineage 1 ) cells (not shown). Within lineage-c-kit 1 cells, apoptosis was most pronounced in megakaryocyte-erythroid progenitors (MEP) ( Supplementary  Fig. 7 ). HSCs are generally more quiescent in close proximity to the endosteal surface in vivo 14 . When we imaged transplanted wild-type cells, we noted that LKS cells located significantly closer to the endosteum in mutant animals compared with controls ( Supplementary  Fig. 8b, c) , and the frequency of cell duplets, an indicator of cell proliferation, was markedly increased ( Supplementary Fig. 8d ), demonstrating increased proliferation of primitive progenitors despite close proximity to the endosteal surface.
OCD fl/fl mice also had reduced B cells and B-cell progenitors, with a concomitant increased frequency of myeloid cells in the bone marrow (Supplementary Figs 2h, i and 9), as observed in human MDS 15, 16 . The nature of the B-cell defect in early MDS has remained elusive because cytogenetic studies have failed to link B cells to the malignant clone in MDS. Interestingly, osteoblasts have recently been shown to constitute a niche for B-cell lymphopoiesis 17, 18 . OCD fl/fl mice also showed variable, but increased vascularity in the bone marrow, a feature that has been described in MDS 19 (Supplementary Fig. 2j ). Deficiencies of either vitamin B12 or folate, which can cause myelodysplastic features 13 , were excluded as contributing factors in the OCD fl/fl mice (not shown).
Myelodysplasia is environmentally induced
Next, we used transplantation to assess the contribution of the microenvironment to the haematopoietic phenotype. Haematopoietic cells of OCD fl/fl (CD45.2) mice demonstrating profound cytopenia and myelodysplastic features were transplanted into B6.SJL (CD45.1) mice ('wild-type environment') ( Fig. 3a) . Transplanted animals were without apparent signs of disease. The assessment of peripheral blood and bone marrow 16 weeks ( Fig. 3a-d and Supplementary Fig. 10 ) or 12 months ( Supplementary Fig. 11 ) after transplant showed nearly complete donor (CD45.2) chimaerism, with complete normalization of cytopenias, granulocyte and megakaryocyte morphology, intramedullary apoptosis of primitive progenitors and bone marrow vascularity. The results indicate that the haematopoietic phenotype cannot be propagated in a haematopoietic cell-autonomous manner. Conversely, when bone marrow cells from wild-type B6.SJL mice were transplanted into lethally irradiated mutant or control mice ( Fig. 3e-h and Supplementary Fig. 12 ), mutant recipients developed leukopenia, anaemia and thrombocytopenia, dysplastic features of CD45.1 blood cells, increased bone marrow vascularity with dysplastic megakaryocytes, increased frequency of myeloid cells, decreased frequency of B-cell subsets and increased apoptosis of primitive haematopoietic progenitors. The combined experiments provide formal proof that the myelodysplastic phenotype observed in mutant mice is determined by the microenvironment.
Osteolineage stage specificity
To examine whether mesenchymal cells of the osteoblastic lineage can directly induce aberrant haematopoiesis, we established bone-marrow-derived stromal cell cultures from OCD fl/1 versus OCD fl/fl mice and co-cultured these with red-fluorescent (DsRed) haematopoietic LKS and MEP cells ( Supplementary Fig. 13 ). Stromal cells were osteolineage-committed as evidenced by osterix expression (and deletion of Dicer1; not shown), but lacked terminally differentiated osteoblasts as indicated by the absence of osteocalcin expression (Supplementary Fig. 13a ). Co-cultures on osterix 1 osteocalcin 2 OCD fl/fl stromal cells showed increased proliferation of LKS cells (Supplementary Fig. 13b-d ) and impaired megakaryocyte differentiation of MEP cells ( Supplementary Fig. 13e -h). The latter was accompanied by morphological changes in megakaryocytic cells ( Supplementary  Fig. 13i ), resembling those observed in vivo. Together, the data show that the disruption of haematopoiesis observed in OCD fl/fl mice in vivo is, at least partly, the result of a direct effect of osterix 1 osteocalcin 2 osteolineage cells on haematopoietic cell proliferation and differentiation. To explore further whether osteoprogenitor cells rather than terminally differentiated (osteocalcin 1 ) osteoblasts were the key participants in the haematopoietic abnormality, we crossed Dicer fl/fl with mice in which Cre recombinase was driven by the osteocalcin promoter. Efficient recombination by osteocalcin-Cre was confirmed as previously demonstrated 20 ( Supplementary Fig. 14a ), and serial dilution of DNA isolated from long bones demonstrated equivalent efficacy of Dicer1 deletion using either the osteocalcin-or osterix-driven Cre (not shown). Dicer1 deletion in this genetic context recapitulated some aspects of the bone phenotype, notably the altered texture and increased volume of cortical bone ( Supplementary Fig. 14b, c) , but did not result in any haematopoietic abnormalities ( Supplementary  Fig. 14d-h) . The data demonstrate that osteoprogenitor cell-specific effects of Dicer1 deletion underlie the disruption of haematopoiesis, and indicate that select subsets of cells in the osteoblast lineage have discrete functions in regulating haematopoiesis.
Emergence of leukaemia
Human MDS is characterized by transformation to acute myeloid leukaemia in a significant subset of patients. Notably, we observed the infrequent occurrence of myeloblastic tumours in OCD fl/fl mice. Four mice were observed to have facial tumours (estimated frequency 2 out of 100 OCD fl/fl animals), of which three animals were available for detailed analysis (Fig. 4a ). Tumours appeared at the age of 2-3 weeks and mice died at age 4-5 weeks. Analyses in a separate cohort of animals demonstrated that dysplastic features were already present in 3-week-old animals ( Supplementary Fig. 15 ), suggesting that tumorigenesis occurred in the context of existing dysplasia. Histological examination of the tumours established a diagnosis of myeloid sarcoma (Fig. 4b) , a soft-tissue complication of acute myelogenous leukaemia (AML). Dicer1 had not been deleted in these myeloid sarcomas as determined by genomic PCR (Fig. 4c ). Comparative genomic hybridization to germline DNA showed genetic abnormalities in all tumours, providing direct evidence that the microenvironment facilitated clonal evolution of tumour cells ( Fig. 4d and Supplementary Fig. 16 ). Cytogenetic abnormalities included amplification of a common (27 kilobase (kb)) region on chromosome 14qC1 in two tumours, the biological relevance of which, in the absence of known genes related to tumorigenesis in this region, is under investigation. The myeloid sarcomas displayed infiltrative behaviour into surrounding tissues ( Supplementary Fig. 17 ) and were diagnosed in a context of myelocytosis ( Fig. 4e) , anaemia (Fig. 4f) , profound splenomegaly with infiltration of blasts ( Fig. 4g, h) , and a marked increase in blasts with a monocytic appearance in blood and bone marrow ( Fig. 4i-k) . This combination of findings strongly resembles monoblastic AML (French-American-British (FAB) subtype AML M4/ M5) in humans, and fulfilled all criteria for the diagnosis of AML in mice 12 . Although the presence of myeloid sarcoma and acute monocytic leukaemia-like disease in OCD fl/fl mice was sporadic, myeloid sarcomas were never observed in OCD fl/1 or Osx-Cre mice (which were fourfold more abundant than mutant animals) and the occurrence of spontaneous AML in mice at age 2-3 weeks is unprecedented to our knowledge. Taken together, these data demonstrate that the disruption of Dicer1 from cells of the osteoblastic lineage causes myelodysplasia in mice recapitulating important characteristics of human MDS, including the propensity to develop AML.
Deletion of Shwachman-Diamond-Bodian syndrome gene
To obtain insight into the genes and molecular pathways in osteolineage cells driving the disruption of haematopoiesis in OCD fl/fl mice, we performed gene expression profiling of primary OCD fl/1 and OCD fl/fl osteolineage cells (GFP 1 CD45 2 lineage 2 CD31 2 ). Microarray analysis showed a broad changes in the transcriptome in OCD fl/fl osteolineage cells, with differential expression of 656 genes (P # 0.05, Student's t-test) representing a wide array of functional groups (Supplementary Table 1 ). Gene set enrichment analysis (GSEA) showed significant enrichment (false discovery rate (FDR) , 0.05) of genes involved in early osteoblastic differentiation and commitment 21 , including the Wnt-b-catenin 9 and TGF-b signalling pathway 22 , in OCD fl/1 samples (Supplementary Table 2 ). Notably, differentially expressed genes and pathways also included stress response genes and cytokines (Supplementary Tables 2 and 3) , with significant downregulation of the Shwachman-Diamond-Bodian syndrome (Sbds) gene (2.43-fold; 24 , and a role for the bone marrow microenvironment in the pathogenesis of the syndrome has been suggested 25 . Targeted Sbds deletion from osteoprogenitor cells by intercrossing osterix-Cre mice to mice containing conditional (floxed) Sbds alleles (Fig. 5a ) (S.Z. et al., manuscript submitted) resulted in altered texture of the cortical bone ( Supplementary Fig. 18a ), leukopenia and lymphopenia (but not neutropenia) ( Fig. 5b) , dysplastic features of neutrophils in the peripheral blood (Fig. 5c ), and micromegakaryocytes ( Fig. 5d ) with increased vascularity of the bone marrow (Fig. 5e ). Further similarities with OCD fl/fl mice included decreased frequency of B cells and B-cell progenitors ( Supplementary Fig. 18b ), increased frequency of myeloid cells ( Supplementary Fig. 18c ) and intramedullary apoptosis of haematopoietic progenitor cells (Fig. 5f) . Collectively, the data show that conditional deletion of Sbds from osteoprogenitor cells recapitulates key characteristics of OCD fl/fl mice, and implicate osteoprogenitor cells in the pathogenesis of the Shwachman-Diamond syndrome.
Discussion
These studies show that specific changes in specific mesenchymal cells of the haematopoietic microenvironment may be sufficient to initiate a complex phenotype of disordered homeostasis with similarities to myelodysplasia, a poorly understood human disease. Furthermore, we demonstrate the ability of this abnormality to result in the emergence of a clonal neoplasm in a cell type of clearly distinct lineage with distinct secondary genetic changes. The data indicate that individual, well-defined, mesenchymal microenvironment constituents can be primary enablers of neoplastic changes in a heterologous cell type. Although a series of genetic and epigenetic events in a single cell may be necessary for oncogenesis, they may not be sufficient, and a permissive microenvironment has been suggested to be required for frank malignancy to emerge 26 . Examples of microenvironmental contributions to neoplasia include a necessary mast cell contribution to Nf1-induced neurofibromas 27 and mesenchymal cell alteration of epithelial tumour growth kinetics 28, 29 . Changes in a tissue microenvironment have also been suggested to precede and promote the initiation of genetic events by creating a 'pre-malignant' state characterized by disruption of quiescence-inducing signals or increases in proliferative signalling 30, 31 . This has been validated experimentally with altered TGF-b signalling in tissue fibroblasts 32 and with myeloid progenitor expansion after RAR-c deletion in bone marrow or Rb deficiency in haematopoietic and microenvironmental cells 33, 34 .
Our findings support the mechanism of malignancy resulting from the interaction of cell autonomous and microenvironmentally determined events, and point to the microenvironment as the site of the initiating event that leads to secondary genetic changes in other cells. It is therefore possible to envision a 'niche-based' model of oncogenesis in which a change in a specific microenvironmental cell can serve as the primary moment in a multi-step process towards malignancy of a supported, but distinct cell type. Signals from the microenvironment may select for subsequent transforming events and therefore such signals may represent candidate therapeutic targets in both treatment and prevention strategies.
Whether osteoprogenitor cell abnormalities are involved in the pathogenesis of human MDS and leukaemia cannot be discerned from our studies. MDS is a heterogeneous disorder in which cytogenetics can be normal or reveal specific clonal lesions such as deletion of 5q. A role for the microenvironment in MDS has been raised, and reduced osteoblast surface and unchanged bone volume similar to our OCD fl/fl model has been reported 35 . Our findings raise the possibility that microenvironmental alterations may precede and facilitate clonal evolution in MDS. Studies examining patient samples will explore this possibility.
The Sbds studies provide further suggestive links to human disease. The human syndrome combines features seen in our model and raises the issue of whether both the pathophysiology of the disorder and the difficulty in treating this syndrome with bone marrow transplantation is in part due to a microenvironmental defect in the bone marrow.
The function of Sbds is itself unclear, but it has been implicated in ribosomal biogenesis 23 and may therefore share with Dicer1 the ability to modulate the gene expression 'landscape'. Although we pursued Sbds because its expression was decreased in the absence of Dicer1, levels in OCS fl/fl are likely to be even lower and as a consequence, may not truly portray the role of Sbds in our model. We therefore regard Sbds as a candidate participant in the phenotype of OCD fl/fl mice, but further studies will be needed to define the collaborating molecules causing the haematopoietic abnormalities.
These studies were initiated focusing on the stem cell niche, but the results indicate that individual microenvironment constituents can serve as regulators of tissue functions beyond that of stem cell support. Osteoprogenitor dysfunction induced altered proliferation and differentiation of both HSCs and distinct haematopoietic progenitor subsets, and induced changes in the tissue architecture. Within a tissue microenvironment, certain elements may have far broader, integrative functions as the osteoprogenitor cells did here. There may be a hierarchy of activity within niche components as well as the cells they regulate. Our studies provide the rationale for further exploration of the complexity of mesenchymal stroma and the role specific mesenchymal subsets may have as primary regulators of normal and disordered tissue function.
METHODS SUMMARY
Mice. Osx-Cre transgenic mice 9 , Ocn-Cre transgenic mice 20 and floxed Dicer1 mice 10 , have been described. B6.SJL-Ptprc a Pep3 b /BoyJ mice were purchased from the Jackson Laboratory. Transplantation. For competitive transplantation, 5 3 10 5 bone marrow cells from 6-week-old OCD fl/1 or OCD fl/fl (CD45.2 1 ) littermates admixed with 5 3 10 5 CD45.1 1 (competitor) wild-type cells were injected into lethally irradiated (9 Gy, split dose) B6.SJL (CD45.1 1 ) mice. For 'wild-type into mutant' experiments, wild-type congenic B6.SJL (CD45.1 1 ) bone marrow cells (1 3 10 6 cells per recipient) were transplanted into lethally irradiated 4-week-old OCD fl/1 and OCD fl/fl (CD45.2 1 ) recipients. For 'mutant into wild-type' experiments, OCD fl/1 or OCD fl/fl (CD45.2 1 ) were transplanted into lethally irradiated 4-week-old B6.SJL (CD45.1 1 ) animals. Donor cell engraftment was confirmed by FACS.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
into the tail vein of recipient mice. Mice were anaesthetized and prepared for in vivo imaging as described. Immediately before imaging, 20 l of non-targeted Qdot 800 or 655 (Invitrogen) diluted in 130 l sterile PBS was injected retroorbitally to allow vasculature visualization. All mice were imaged with a custom-built confocal two-photon hybrid microscope specifically designed for live animal imaging. Microscopy and image processing have been described. Images were coloured and merged using Adobe Photoshop and LKSmicroenvironment distance measures were obtained using Adobe Illustrator and Microsoft Excel. A two-tailed type 2 t-test was applied to all data. P # 0.05 was considered statistically significant.
Co-culture studies. Bone marrow stromal cells were isolated and CD45-depleted by magnetic isolation upon confluence and expanded for another week. The expanded cells were then plated at 1,750 cells per well in 384-well tissue culture plates coated with fibronectin (Millipore) in either aMEM20% or osteogenic induction media. After 4 days of culture, 200 LKS or MEP (lineage 2 , CD127 2 Sca1 2 c-kit 1 CD34 2 CD16/32 2 cells) cells from 8-12-week-old Actin-DsRed positive mice (Jackson Laboratory; 005441) were added to each well. Co-culture was performed without any cytokines. After 7 days of co-culture the number of DsRed cells was assessed by automated microscopy. Megakaryocytes were quantified morphologically as large cells with prominent multinucleated megakaryons (the identity of these cells was also confirmed by CD41 staining).
Comparative genomic hybrydization. Direct amplification of DNA from paraformaldehyde-fixed paraffin-embedded (FFPE) tissue samples was performed using a REPLI-g FFPE kit (Qiagen) following the manufacturer's instructions. In brief, FFPE samples were incubated at 95 uC for 10 min followed by lysis at 60 uC for 60 min and ligation at 24 uC for 30 min. Amplification took place at 30 uC for 2 h. Agilent genomic DNA labelling kit was used for the amplified FFPE DNA labelling and purification. For each 244 K array, 2 mg of FFPE DNA and 2 mg of germline reference DNA were labelled with Cy5 and Cy3, respectively. Labelled FFPE DNA and reference DNA were combined and mixed with Cot-1 DNA, blocking agent and hybridization buffer. After denaturation at 95 uC for 3 min and incubation at 37 uC for 30 min, the hybridization mix was loaded onto a gasket slide in an Agilent Surehyb chamber. The array slide was placed on top the gasket slide. The SureHyb chamber was covered, clamped and incubated in a rotator rack in a 65 uC oven for 40 h. In an ozone-controlled environment, hybridized arrays were disassembled, and washed in Agilent Oligo aCGH wash buffer 1 for 5 min, in wash buffer 2 for 1 min at 37 uC, and immediately scanned using an Agilent DNA microarray scanner. Data extraction was conducted using the feature extraction software. Finally, data files were analysed using the Agilent DNA analytics software. Oligonucleotide microarrays. RNA was isolated from sorted GFP 1 CD45 2 CD31 2 lineage 2 cells by Trizol extraction (Invitrogen) according to the manufacturer's protocol. Up to four mice were pooled per sample. Linear amplification of 20 ng total RNA was performed using the Ovation Biotin RNA Amplification and Labelling System (Nugen). The biotinylated cRNA was hybridized to the Affymetrix Mouse430 v2 chip. Signal normalization was performed by the robust multiarray averaging (RMA) method. Data of three samples of OCD fl/fl cells versus three samples of OCD fl/1 cells was analysed using GEPAS package 38 . A t-test was carried to identify probes differentially expressed between OCD fl/1 and OCD fl/fl samples. Gene set enrichment analysis was performed as described 39 . The signal-to-noise metric and permutation of gene sets was used to rank the genes and calculate significance and FDR values. Analysis was performed by collapsing probe sets to unique gene symbols and used to interrogate an established collection of curated gene sets provided by the Molecular Signatures Database (MsigDB, http://broad.mit.edu/gsea/msigdb). The osteogenic gene expression signature was collected from the literature 21 and used to interrogate the gene expression data set comparing OCD fl/1 and OCD fl/fl samples for gene set enrichment. Statistical analysis. In all cases, analysis was performed by a standard unpaired, two-tailed Student's t test. All data have been plotted as mean 6 s.e.m. Statistical significance is indicated by *P # 0.05 or **P # 0.01.
